Bayesian Rule Learning Methods for Disease Prediction and Biomarker Discovery

用于疾病预测和生物标志物发现的贝叶斯规则学习方法

• 批准号: 8318619
• 负责人: Vanathi Gopalakrishnan
• 金额: $ 46.61万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-15 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8318619
• 关键词: Address; Amyotrophic Lateral Sclerosis; Area; Bayesian Method; Biological Markers; Breast; Breast Cancer Early Detection; Characteristics; Classification; Clinical; Collaborations; Coupled; Data; Data Analyses; Data Set; Decision Trees; Development; Diagnostic tests; Disease; Disease model; Early Diagnosis; Evaluation; Foundations; Goals; Human; Hybrids; Informatics; Internet; Knowledge; Knowledge Discovery; Lead; Learning; Machine Learning; Malignant Neoplasms; Malignant neoplasm of lung; Methodology; Methods; Modeling; Molecular; Nerve Degeneration; Outcomes Research; Performance; Programmed Learning; Proteomics; Protocols documentation; Publishing; Rare Diseases; Research; Sample Size; Sampling; Scientist; Screening procedure; Serum; Solutions; Source; Space Models; Structure; Techniques; Technology; Testing; Training; Translating; Trees; Uncertainty; Validation; Work; base; computer based statistical methods; data mining; design; fundamental research; high throughput analysis; high throughput technology; improved; information organization; insight; malignant breast neoplasm; novel; novel diagnostics; predictive modeling; programs; tool

DESCRIPTION (provided by applicant): The problem: High-throughput biomedical data from biomarker profiling studies aimed at early detection of diseases like lung cancer are accumulating rapidly. Although many popular machine learning methods have been utilized for analysis of such high-dimensional datasets, no single method has consistently outperformed others. Moreover, scientists have the need to simultaneously address two related tasks: disease prediction and biomarker discovery, using the same sets of data and tools. One way, as undertaken in this project, to address this need is to find the most accurate classifier for the disease from a given set of profiles and present the discriminative markers used in that model to the scientist for further verification. The large space of possible models coupled with the small sample size of the data make it hard to accurately estimate predictive accuracy. The solution: This project will develop, evaluate and refine novel Bayesian Rule Learning (BRL) methods that are algorithmically efficient, result in parsimonious models and accurately estimate predictive uncertainty from sparse biomedical datasets. BRL methods utilize a Bayesian score to evaluate rule models, thereby quantifying the uncertainty in the validity of the rule itself. This novel technique that combines the mathematical rigor of Bayesian network learning with rule-based modeling opens up a hitherto underexplored area of fundamental research in informatics involving such hybrid methodologies. Rules enable modular representation of knowledge and collaboration with scientists, as it is easier to present the model and extract markers both visually and computationally. Rule-based inference is also simpler and more tractable. The Bayesian approach enables prior knowledge to be incorporated and evaluated in a continual fashion with a human in the loop. The latter is very important for refinement of both tools and models. The specific aims: This project will test the hypothesis that the BRL methods developed and extended herein produce more accurate and parsimonious models for disease state prediction than other state-of-the-art machine learning methods. This project evaluates BRL methods and models using existing proteomic datasets for three diverse diseases - rare, neurodegenerative Amyotrophic Lateral Sclerosis (ALS), and the two most common cancers in the world, lung and breast cancers. Experimental verification will be performed using a new set of retrospectively collected breast cancer sera samples to evaluate model generalizability. The significance: This project will produce: (1) a novel biomedical data mining tool for analyzing data from biomarker profiling studies of any disease, (2) methodological insights into the applicability of this tool and current machine learning methods for such tasks, and (3) new data for research on the early detection of breast cancer. It has potential to help develop new diagnostic tests for early detection of ALS, lung and breast cancers and lays a firm foundation for building modeling frameworks that can incorporate both prior knowledge and data to provide the technological capability for combining evidence from multiple, heterogeneous sources.

描述（由申请人提供）：